Allstate Corporation’s Akero Therapeutics AKRO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-8,384	Closed	-$208K	–	691
2021 Q2	$208K	Buy	8,384 +97	+1%	+$2.41K	0.01%	706
2021 Q1	$240K	Buy	+8,287	New	+$240K	0.01%	689